DB-1310 by Duality Biologics (Shanghai) for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval

The FDA has ap­proved As­traZeneca’s Imfinzi to treat lim­it­ed-stage small cell lung can­cer, adding an­oth­er lung can­cer in­di­ca­tion to one of the phar­ma’s best-sell­ing drugs

Fol­low­ing years of ac­cu­sa­tions of sci­en­tif­ic malfea­sance, Alzheimer’s drug de­vel­op­er Cas­sa­va Sci­ences dis­closed Mon­day that two of its se­nior em­ploy­ees are be­ing in­ves­ti­gat­ed by the